Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
Medical Information e-mail: medicalinformationuk@merck.com

Patient Information Leaflet last updated on the eMC: 23/08/2011
PIL SINGULAIR PAEDIATRIC 4 mg GRANULES

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 23/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
Updated on 05/07/2010 and displayed until 23/08/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 07/09/2009 and displayed until 05/07/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 23/03/2009 and displayed until 07/09/2009
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to side-effects
Updated on 08/08/2008 and displayed until 23/03/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 16/05/2008 and displayed until 08/08/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 07/12/2007 and displayed until 16/05/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change due to harmonisation of patient information leaflet
  • Change due to user-testing of patient information
Updated on 07/07/2006 and displayed until 07/12/2007
Reasons for adding or updating:
  • Change to drug interactions
Updated on 02/05/2006 and displayed until 07/07/2006
Reasons for adding or updating:
  • Change to, or new, use for medicine
Updated on 27/01/2006 and displayed until 02/05/2006
Reasons for adding or updating:
  • Change to side-effects
  • Change to drug interactions
Updated on 01/03/2004 and displayed until 27/01/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   montelukast sodium